Get the Stockscreener App
195.87
3.30%
6.26
After Hours:
194.10
-1.77
-0.90%
Overview
News
Price History
Option Chain
Financials
Why DHR Down?
Discussions
Forecast
Stock Split
Dividend History
Danaher Corp stock is traded at $195.87, with a volume of 4.84M.
It is up +3.30% in the last 24 hours and up +4.56% over the past month.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
See More
Previous Close:
$189.61
Open:
$188.67
24h Volume:
4.84M
Relative Volume:
1.19
Market Cap:
$138.62B
Revenue:
$24.57B
Net Income/Loss:
$3.60B
P/E Ratio:
38.78
EPS:
5.051
Net Cash Flow:
$5.26B
1W Performance:
+1.95%
1M Performance:
+4.56%
6M Performance:
-4.52%
1Y Performance:
+3.78%
1-Day Range:
$188.06
$196.51
1-Week Range:
$188.06
$198.56
52-Week Range:
$180.03
$242.80
Danaher Corp Stock (DHR) Company Profile
Name
Danaher Corp
Sector
Industry
Phone
(202) 828-0850
Address
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
195.87 | 134.19B | 24.57B | 3.60B | 5.26B | 5.051 |
TMO
Thermo Fisher Scientific Inc
|
514.23 | 184.37B | 44.56B | 6.72B | 6.29B | 17.74 |
IDXX
Idexx Laboratories Inc
|
574.00 | 44.72B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
117.50 | 32.52B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
324.68 | 31.41B | 3.17B | 642.63M | 516.49M | 10.77 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Apr-10-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-21-25 | Upgrade | Goldman | Neutral → Buy |
| Mar-14-25 | Upgrade | Stifel | Hold → Buy |
| Feb-03-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-31-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-18-23 | Initiated | HSBC Securities | Hold |
| Dec-13-23 | Resumed | Wolfe Research | Peer Perform |
| Dec-07-23 | Downgrade | Goldman | Buy → Neutral |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-01-23 | Initiated | SVB Securities | Outperform |
| Apr-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-18-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Oct-24-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-17-22 | Resumed | Bernstein | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jun-01-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-11-22 | Initiated | Bernstein | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-10-21 | Reiterated | BofA Securities | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Reiterated | Goldman | Buy |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Apr-07-21 | Resumed | Robert W. Baird | Outperform |
| Mar-03-21 | Resumed | Barclays | Overweight |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-02-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-26-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-03-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Resumed | Stifel | Hold |
| Oct-28-19 | Reiterated | Needham | Buy |
| Oct-14-19 | Resumed | Credit Suisse | Outperform |
| Jul-19-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Feb-25-19 | Upgrade | Janney | Neutral → Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Apr-20-18 | Reiterated | Stifel | Buy |
View All
Danaher Corp Stock (DHR) Latest News
Danaher Corp (DHR) Stock Up 3.3% and Still Undervalued -- GF Sco - GuruFocus
Danaher Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
DHR Maintained by Goldman Sachs -- Price Target Lowered to $230 - GuruFocus
The Goldman Sachs Group Lowers Danaher (NYSE:DHR) Price Target to $230.00 - MarketBeat
Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - GlobeNewswire Inc.
State of Alaska Department of Revenue Decreases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes - PR Newswire
Best Biotech Stocks To Keep An Eye OnApril 12th - MarketBeat
Sumitomo Mitsui Trust Group Inc. Cuts Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Bought by Robeco Institutional Asset Management B.V. - MarketBeat
What to expect from Danaher Corporation's Q1 2026 earnings report - MSN
Massachusetts Financial Services Co. MA Boosts Stake in Danaher Corporation $DHR - MarketBeat
Factory Mutual Insurance Co. Sells 5,500 Shares of Danaher Corporation $DHR - MarketBeat
Bar Harbor Wealth Management Has $14.72 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corp. stock underperforms Friday when compared to competitors - MarketWatch
Promising Biotech Stocks To Follow TodayApril 10th - MarketBeat
GENERAL AMERICAN INVESTORS CO INC's Danaher Corp(DHR) Holding History - GuruFocus
Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.
Douglas Lane & Associates LLC Grows Position in Danaher Corporation $DHR - MarketBeat
Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders? - Finviz
Danaher Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Published on: 2026-04-10 13:38:44 - baoquankhu1.vn
Danaher Corporation (DHR) stock price, news, quote and history - Yahoo Finance UK
Masimo stock price target raised to $180 by Jefferies on Danaher deal - Investing.com Australia
Danaher Corporation $DHR Stock Holdings Cut by CCLA Investment Management - MarketBeat
DHR Stock Price, Quote & Chart | DANAHER CORP (NYSE:DHR) - ChartMill
Support Test: Whats the beta of Danaher Corporation stockQuarterly Trade Summary & Reliable Price Breakout Signals - baoquankhu1.vn
Danaher Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Biotech Stocks To Keep An Eye OnApril 8th - MarketBeat
Danaher Corp. Experiences Revision in Its Stock Evaluation Amid Competitive Market Landscape - Markets Mojo
Danaher (NYSE:DHR) Given New $230.00 Price Target at Wolfe Research - MarketBeat
Jefferies Financial Group Has Lowered Expectations for Danaher (NYSE:DHR) Stock Price - MarketBeat
9,123 Shares in Danaher Corporation $DHR Purchased by Oak Thistle LLC - MarketBeat
Sivik Global Healthcare LLC Trims Stock Holdings in Danaher Corporation $DHR - MarketBeat
GREENWOOD CAPITAL ASSOCIATES LLC's Danaher Corp(DHR) Holding History - GuruFocus
Danaher Corporation $DHR Shares Acquired by Aaron Wealth Advisors LLC - MarketBeat
Evercore ISI Cuts Danaher (DHR) Price Target, Adds Shares to Tactical Outperform List - Insider Monkey
Biotech Stocks To Watch NowApril 7th - MarketBeat
Evaluating Danaher (DHR) After Mixed Recent Returns And Conflicting Undervaluation Signals - simplywall.st
Fulton Breakefield Broenniman LLC Reduces Stock Holdings in Danaher Corporation $DHR - MarketBeat
The Osterweis Fund's Danaher Corp(DHR) Holding History - GuruFocus
Danaher Corporation (DHR) Stock Price, News, Quote & History - ca.finance.yahoo.com
Danaher (DHR) Analyst Rating: Evercore ISI Lowers Price Target | - GuruFocus
Best Biotech Stocks To ConsiderApril 6th - MarketBeat
Danaher Corporation (DHR) Stock Forecasts - Yahoo Finance
Danaher: After a Long Reset Period, Profit Growth Looks Likely to Accelerate in the Medium Term - Morningstar
Evercore Cuts Danaher (NYSE:DHR) Price Target to $225.00 - MarketBeat
Danaher: A Great Way To Play Healthcare For Long-Term Dividend Growth Investors (DHR) - Seeking Alpha
What to Expect From Danaher Corporation's Q1 2026 Earnings Report - Barchart
Rathbones Group PLC Has $60.78 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
Major Investors Accumulate Danaher Shares Amid Price Weakness - AD HOC NEWS
Danaher Corp Stock (DHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):